Therapy of severe multidrug-resistant (MDR) Gram-negative bacterial infections. Active against Pseudomonas aeruginosa infections, Acinetobacter baumannii infections, Klebsiella pneumoniae infections. Applied in septicemia, pneumonia, urinary tract infection, intra-abdominal infection, and meningitis (in case of failure of other antibiotics).